Compliance certificate under Reg. 74(5) of SEBI (DP) for the quarter ended 31.03.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kobo Biotech has submitted a quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March 2026. The certificate was issued by the company's Registrar and Share Transfer Agent (RTA), XL Softech Systems Ltd. It confirms that all securities received for dematerialization during the quarter were properly confirmed to the depositories, listed on the stock exchange, mutilated, cancelled after due verification, and the depositories' names were substituted in the register of members within the required 30-day timeline. The letter is signed by the Resolution Professional, indicating the company is still under the Corporate Insolvency Resolution Process (CIRP) under the IBC.
This is a routine procedural compliance filing and does not signal any new business development. However, the continued involvement of a Resolution Professional confirms the company remains under CIRP, meaning shareholders should expect resolution process updates to be the main value drivers going forward.